The sequential change of NTBI and iron metabolic markers after oral iron administration in HD patients

The sequential change of NTBI and iron metabolic markers after oral iron administration in HD patients - The change of NTBI and iron metabolic markers after iron po in HD patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1091220300

Enrollment

Registered

2017-06-28

Start date

2017-03-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis patients

Interventions

Intervention type:DRUG Name of intervention:ferrous sulfate Dose form / Japanese Medical Device Nomenclature:TABLET Route of administration / Site of application:ORAL Dose per administration:105 105 m

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: HD patients

Exclusion criteria

Exclusion criteria: Ferritin>100mg/dl Hb>12g/dl

Design outcomes

Primary

Measure	Time frame
Assay of Serum concentration of NTBI and iron metabolic markers after oral iron administration	—

Countries

Japan

Contacts

Public ContactShigeru Miyazaki

Shinraku-en Hospital

byori@shinrakuen.com+81-25-260-8200

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026